Addus HomeCare Corporation (NASDAQ:ADUS) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Addus HomeCare Corporation (NASDAQ:ADUS) have earned a consensus recommendation of “Moderate Buy” from the eleven research firms that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $131.50.

Several research analysts have commented on the stock. Barclays raised their target price on shares of Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a report on Wednesday, July 8th. Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a report on Friday, July 24th. Weiss Ratings upgraded shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Finally, Citizens Jmp reaffirmed a “market outperform” rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Monday, May 18th.

Addus HomeCare Stock Down 0.1%

Shares of Addus HomeCare stock opened at $119.13 on Thursday. The business’s fifty day moving average price is $100.75 and its two-hundred day moving average price is $101.32. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.83 and a quick ratio of 1.83. The company has a market capitalization of $2.22 billion, a P/E ratio of 22.02, a PEG ratio of 1.63 and a beta of 0.88. Addus HomeCare has a 1-year low of $87.95 and a 1-year high of $124.43.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, May 4th. The company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.52 by $0.10. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The firm had revenue of $363.50 million for the quarter, compared to analysts’ expectations of $366.41 million. During the same quarter in the previous year, the company earned $1.42 earnings per share. The firm’s quarterly revenue was up 7.7% compared to the same quarter last year. As a group, research analysts forecast that Addus HomeCare will post 6.24 EPS for the current year.

Insider Activity at Addus HomeCare

In other news, insider Heather Brianne Dixon sold 288 shares of the stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $93.77, for a total transaction of $27,005.76. Following the transaction, the insider owned 44,371 shares in the company, valued at $4,160,668.67. This represents a 0.64% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 788 shares of company stock valued at $73,506. Insiders own 4.10% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Global Retirement Partners LLC increased its stake in shares of Addus HomeCare by 395.7% in the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after purchasing an additional 186 shares during the period. Larson Financial Group LLC lifted its position in shares of Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after purchasing an additional 136 shares during the last quarter. Acumen Wealth Advisors LLC bought a new stake in Addus HomeCare during the 4th quarter valued at approximately $29,000. Private Trust Co. NA boosted its stake in Addus HomeCare by 65.5% during the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock valued at $30,000 after purchasing an additional 112 shares during the period. Finally, Arax Advisory Partners grew its holdings in Addus HomeCare by 95.8% in the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after buying an additional 137 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.